doxycycline hyclate NDC 62332-362

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-362Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0362Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62332-362-50	62332036250	50 CAPSULE in 1 BOTTLE (62332-362-50)Marketed from Jun 18, 2018
62332-362-71	62332036271	500 CAPSULE in 1 BOTTLE (62332-362-71)Marketed from Jun 18, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): doxycycline hyclate
Generic name (nonproprietary): doxycycline hyclate
Active ingredients: Doxycycline hyclate — 50 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Alembic Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210527
Marketing start: Jun 18, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Tetracyclines (Chemical structure)
Identifiers: Product ID 62332-362_2a82cd02-f9ad-41c6-8c57-21ae980b3a39SPL ID 2a82cd02-f9ad-41c6-8c57-21ae980b3a39SPL set ID 131af052-0c4f-4a61-ae9a-e6165ae09076RxCUI 1649405, 1649988UNII 19XTS3T51U
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332036250 followed by a unit qualifier and the quantity

Package 62332-0362-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 19, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate capsules, USP and other antibacterial drugs, doxycycline hyclate capsules, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Treatment: Doxycycline is indicated for the treatment of the following infections: Rocky Mountain spotted f…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210527

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210527
Product	Strength	Form · route	Labeler	Product NDC
doxycycline hyclate	Doxycycline hyclate 50 mg/1	CapsuleOral	Alembic Pharmaceuticals Limited	46708-362
doxycycline hyclate	Doxycycline hyclate 100 mg/1	CapsuleOral	Alembic Pharmaceuticals Limited	46708-363
doxycycline hyclate	Doxycycline hyclate 100 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-363